Adaptive Biotechnologies (ADPT) Other Non-Current Assets (2018 - 2026)

Adaptive Biotechnologies has disclosed Other Non-Current Assets across 9 years of filings, most recently posting $2.7 million for Q2 2026.

• In Q2 2026, Other Non-Current Assets changed 0.29% year-over-year to $2.7 million; the TTM figure through Jun 2026 stood at $2.7 million (changed 0.29% YoY), while the FY2025 annual figure was $2.7 million, down 6.9% from the prior year.
• Other Non-Current Assets came in at $2.7 million for Q2 2026 at Adaptive Biotechnologies, up from $2.7 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $3.6 million in Q4 2023 to a low of $2.3 million in Q1 2023.
• Average Other Non-Current Assets over 5 years is $2.8 million, with a median of $2.7 million recorded in 2025.
• Year-over-year, Other Non-Current Assets surged 49.63% in 2023 and slipped 20.03% in 2025.
• Over 5 years, Other Non-Current Assets stood at $2.4 million in 2022, then surged by 49.62% to $3.6 million in 2023, then slipped by 19.24% to $2.9 million in 2024, then slipped by 6.9% to $2.7 million in 2025, then climbed by 1.04% to $2.7 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $2.7 million in Q2 2026, $2.7 million in Q1 2026, and $2.7 million in Q4 2025.